Global Penny Stocks To Watch In March 2025

As global markets navigate heightened uncertainty, with the Federal Reserve maintaining steady interest rates and mixed economic data emerging from major regions, investors are keenly observing potential opportunities. Penny stocks, a term that may seem outdated but still signifies small or emerging companies, offer unique growth possibilities at lower price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover hidden gems that might provide stability and upside potential amidst current market conditions.

Top 10 Penny Stocks Globally

Click here to see the full list of 5,719 stocks from our Global Penny Stocks screener.

Let's take a closer look at a couple of our picks from the screened companies.

Sanford (NZSE:SAN)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Sanford Limited is involved in the farming, harvesting, processing, storage, and marketing of seafood products with a market cap of NZ$459.12 million.

Operations: The company generates NZ$582.91 million in revenue from its activities related to seafood products, including farming, harvesting, processing, and selling.

Market Cap: NZ$459.12M

Sanford Limited, with a market cap of NZ$459.12 million and revenue of NZ$582.91 million, shows mixed performance as a penny stock candidate. It has experienced significant earnings growth of 96.5% over the past year, surpassing its five-year average decline, and its net profit margins have improved from 1.8% to 3.4%. The company's return on equity is low at 2.8%, but debt levels are satisfactory with interest payments well covered by EBIT (3.2x). While short-term assets cover liabilities comfortably, long-term liabilities slightly exceed short-term assets by NZ$3.1M, highlighting potential financial challenges ahead.

• Click here to discover the nuances of Sanford with our detailed analytical financial health report.
• Review our growth performance report to gain insights into Sanford's future.

Vista Land & Lifescapes (PSE:VLL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Vista Land & Lifescapes, Inc. is an investment holding company that functions as an integrated property developer and homebuilder in the Philippines, with a market cap of ₱20.32 billion.

Operations: The company generates revenue primarily from its operations in the Philippines, totaling ₱35.61 billion.

Market Cap: ₱20.32B

Vista Land & Lifescapes, Inc., with a market cap of ₱20.32 billion and revenue of ₱35.61 billion, presents a mixed profile as an investment option. The company is trading below its estimated fair value and has seasoned leadership with an experienced board averaging 11.2 years in tenure. Despite low return on equity at 8%, VLL's earnings growth has accelerated to 2.9% over the past year, surpassing its five-year decline average of -2.5%. However, high net debt to equity at 111.1% and inadequate operating cash flow coverage pose financial risks despite stable weekly volatility and well-covered interest payments by EBIT (4x).

• Take a closer look at Vista Land & Lifescapes' potential here in our financial health report.
• Assess Vista Land & Lifescapes' future earnings estimates with our detailed growth reports.

Raffles Medical Group (SGX:BSL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Raffles Medical Group Ltd is a healthcare company offering integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan with a market cap of SGD1.87 billion.

Operations: The company's revenue is primarily derived from Hospital Services (SGD345.65 million), Healthcare Services (SGD295.05 million), and Insurance Services (SGD177.99 million).

Market Cap: SGD1.87B

Raffles Medical Group Ltd, with a market cap of SGD1.87 billion, offers an intriguing investment profile. The company is trading at 38.7% below its estimated fair value and has reduced its debt to equity ratio from 21% to 5.7% over five years, now holding more cash than total debt. Despite stable weekly volatility and seasoned management, recent earnings have declined by 31%, impacting profit margins which fell from 12.7% to 8.3%. However, short-term assets exceed both short-term and long-term liabilities significantly, ensuring financial stability amid ongoing share repurchases and dividend increases announced in early 2025.

• Click here and access our complete financial health analysis report to understand the dynamics of Raffles Medical Group.
• Gain insights into Raffles Medical Group's outlook and expected performance with our report on the company's earnings estimates.

Make It Happen

• Click through to start exploring the rest of the 5,716 Global Penny Stocks now.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com